Biosergen AS (BIOSGN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.954x

Based on the latest financial reports, Biosergen AS (BIOSGN) has a cash flow conversion efficiency ratio of -0.954x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.75 Million ≈ $-833.70K USD) by net assets (Skr8.12 Million ≈ $873.52K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Biosergen AS (BIOSGN) balance sheet quality index to measure how much of total assets are equity-financed.

Biosergen AS - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Biosergen AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Biosergen AS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Biosergen AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biosergen AS ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sienna Resources Inc V:SIE	-0.071x
Lypsa Gems & Jewellery Limited NSE:LYPSAGEMS	0.052x
Reliance Global Group, Inc. NASDAQ:EZRA	-0.077x
SRx Health Solutions Inc. NYSE MKT:SRXH	18.676x
Conduit Capital Ltd JSE:CND	-0.290x
Goldcliff Resource Corp V:GCN	0.001x
ProAm Explorations Corp V:PMX	0.370x
Solid Clouds hf IC:SOLID	N/A

Annual Cash Flow Conversion Efficiency for Biosergen AS (2019–2025)

The table below shows the annual cash flow conversion efficiency of Biosergen AS from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see BIOSGN market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr8.12 Million ≈ $873.52K	Skr-35.53 Million ≈ $-3.82 Million	-4.378x	-1193.49%
2024-12-31	Skr49.14 Million ≈ $5.29 Million	Skr-16.63 Million ≈ $-1.79 Million	-0.338x	+97.80%
2023-12-31	Skr2.12 Million ≈ $227.72K	Skr-32.60 Million ≈ $-3.51 Million	-15.408x	-1092.92%
2022-12-31	Skr22.79 Million ≈ $2.45 Million	Skr-29.44 Million ≈ $-3.17 Million	-1.292x	+30.77%
2021-12-31	Skr20.23 Million ≈ $2.18 Million	Skr-37.75 Million ≈ $-4.06 Million	-1.866x	-544.61%
2020-12-31	Skr-10.92 Million ≈ $-1.18 Million	Skr-4.58 Million ≈ $-493.31K	0.420x	-14.94%
2019-12-31	Skr-4.69 Million ≈ $-504.90K	Skr-2.31 Million ≈ $-249.07K	0.493x	--

About Biosergen AS

ST:BIOSGN Sweden Biotechnology

Market Cap

$1.47 Million

Skr13.62 Million SEK

Market Cap Rank

#30272 Global

#704 in Sweden

Share Price

Skr5.80

Change (1 day)

-3.33%

52-Week Range

Skr0.43 - Skr50.40

All Time High

Skr50.40